Nelde; Annika

Patent Applications and Registrations

Patent applications and USPTO patent grants for Nelde; Annika.The latest application filed is for "peptides and combination of peptides for use in immunotherapy against leukemias and other cancers".

Company Profile

14.7.15

Nelde; Annika - Tuebingen DE
Nelde; Annika - Tubingen DE

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Peptides and combination thereof for use in the immunotherapy against cancers Grant 11,427,614 - Walz , et al. August 30, 2	2022-08-30
Peptides And Combination Of Peptides For Use In Immunotherapy Against Leukemias And Other Cancers App 20220118016 - WALZ; Juliane Sarah ; et al.	2022-04-21
Peptides And Combination Thereof For Use In The Immunotherapy Against Cancers App 20210322478 - WALZ; Juliane Sarah ; et al.	2021-10-21
Peptides and combination of peptides for use in immunotherapy against leukemias and other cancers Grant 11,135,246 - Walz , et al. October 5, 2	2021-10-05
Peptides and combination thereof for use in the immunotherapy against cancers Grant 11,103,534 - Walz , et al. August 31, 2	2021-08-31
Peptides And Combination Thereof For Use In The Immunotherapy Against Cancers App 20210213065 - WALZ; Juliane Sarah ; et al.	2021-07-15
Peptides And Combination Of Peptides For Use In Immunotherapy Against Leukemias And Other Cancers App 20210161962 - WALZ; Juliane Sarah ; et al.	2021-06-03
Peptides and combination thereof for use in the immunotherapy against cancers Grant 11,020,432 - Walz , et al. June 1, 2	2021-06-01
Peptides and combination thereof for use in the immunotherapy against cancers Grant 11,007,223 - Walz , et al. May 18, 2	2021-05-18
Peptides and combination of peptides for use in immunotherapy against leukemias and other cancers Grant 10,993,963 - Walz , et al. May 4, 2	2021-05-04
Peptides and combination of peptides for use in immunotherapy against leukemias and other cancers Grant 10,899,819 - Walz , et al. January 26, 2	2021-01-26
Peptides And Combination Thereof For Use In The Immunotherapy Against Cancers App 20200339656 - WALZ; Juliane Sarah ; et al.	2020-10-29
Peptides And Combination Thereof For Use In The Immunotherapy Against Cancers App 20200339658 - WALZ; Juliane Sarah ; et al.	2020-10-29
Peptides And Combination Thereof For Use In The Immunotherapy Against Cancers App 20200339657 - WALZ; Juliane Sarah ; et al.	2020-10-29
Peptides And Combination Thereof For Use In The Immunotherapy Against Cancers App 20200223900 - WALZ; Juliane Sarah ; et al.	2020-07-16
Peptides And Combination Of Peptides For Use In Immunotherapy Against Leukemias And Other Cancers App 20200207831 - WALZ; Juliane Sarah ; et al.	2020-07-02
Peptides And Combination Thereof For Use In The Immunotherapy Against Cancers App 20200199194 - WALZ; Juliane Sarah ; et al.	2020-06-25
Peptides And Combination Of Peptides For Use In Immunotherapy Against Leukemias And Other Cancers App 20200199193 - WALZ; Juliane Sarah ; et al.	2020-06-25
Peptides And Combination Thereof For Use In The Immunotherapy Against Cancers App 20200190160 - WALZ; Juliane Sarah ; et al.	2020-06-18
Peptides And Combination Of Peptides For Use In Immunotherapy Against Leukemias And Other Cancers App 20200181233 - WALZ; Juliane Sarah ; et al.	2020-06-11
Peptides And Combination Thereof For Use In The Immunotherapy Against Cancers App 20180291082 - WALZ; Juliane Sarah ; et al.	2018-10-11
Peptides And Combination Of Peptides For Use In Immunotherapy Against Leukemias And Other Cancers App 20180291083 - WALZ; Juliane Sarah ; et al.	2018-10-11

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.